RWS Life Sciences Welcomes New VP of Quality
Clarice Streets joins RWS as VP of Quality for Life Sciences Division RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ,…
Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints measuring Safety,…